How Covid Policy Tore Israel Apart
SHARE | PRINT | EMAIL
The rules of medical confidentiality between the patient and the entity treating them must be strengthened, and a person's medical preferences and choices regar... Read more.
Gilad Haran is a professor in the Department of Chemical and Biological Physics at the Weizmann Institute of Science. He served as the Dean of Chemistry in the Institute. Was involved in the development of the first-ever nano-drug, Doxil. Develops and applies in his lab novel methods for studying how proteins operate as tiny machines.